Latest Insider Transactions at I Teos Therapeutics, Inc. (ITOS)
This section provides a real-time view of insider transactions for I Teos Therapeutics, Inc. (ITOS). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of iTeos Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of iTeos Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Nov 17
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.5%
|
-
|
|
Nov 17
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.5%
|
-
|
|
Nov 17
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
15,671
-0.31%
|
-
|
|
Nov 03
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
6,085
-7.37%
|
$170,380
$28.89 P/Share
|
|
Nov 02
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
14,391
-14.85%
|
$402,948
$28.41 P/Share
|
|
Nov 01
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
81
-0.08%
|
$2,268
$28.0 P/Share
|
|
Oct 21
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
196
-0.2%
|
$5,488
$28.0 P/Share
|
|
Oct 19
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
201
-0.21%
|
$5,628
$28.0 P/Share
|
|
Oct 18
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,167
-0.2%
|
$166,509
$27.14 P/Share
|
|
Oct 18
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,167
-0.2%
|
$166,509
$27.14 P/Share
|
|
Oct 18
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,320
-0.2%
|
$278,640
$27.14 P/Share
|
|
Oct 15
2021
|
Michel Detheux Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
1,635
-1.65%
|
$45,780
$28.01 P/Share
|
|
Oct 15
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,932
-0.17%
|
$295,164
$27.77 P/Share
|
|
Oct 15
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
10,932
-0.17%
|
$295,164
$27.77 P/Share
|
|
Oct 15
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
18,295
-0.18%
|
$493,965
$27.77 P/Share
|
|
Oct 14
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,320
-0.86%
|
$737,640
$27.3 P/Share
|
|
Oct 14
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
27,320
-0.86%
|
$737,640
$27.3 P/Share
|
|
Oct 14
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
45,719
-0.88%
|
$1,234,413
$27.3 P/Share
|
|
Oct 13
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,929
-0.65%
|
$565,083
$27.13 P/Share
|
|
Oct 13
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,929
-0.65%
|
$565,083
$27.13 P/Share
|
|
Oct 13
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
35,023
-0.67%
|
$945,621
$27.13 P/Share
|
|
Oct 12
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,521
-0.27%
|
$230,067
$27.09 P/Share
|
|
Oct 12
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
8,521
-0.27%
|
$230,067
$27.09 P/Share
|
|
Oct 12
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
14,260
-0.27%
|
$385,020
$27.09 P/Share
|
|
Oct 11
2021
|
Matthew Gall Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
14,429
+42.62%
|
$86,574
$6.16 P/Share
|
|
Oct 11
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,812
-1.5%
|
$1,317,924
$27.24 P/Share
|
|
Oct 11
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
48,812
-1.5%
|
$1,317,924
$27.24 P/Share
|
|
Oct 11
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
81,684
-1.53%
|
$2,205,468
$27.24 P/Share
|
|
Oct 08
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,032
-0.06%
|
$54,864
$27.01 P/Share
|
|
Oct 08
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,032
-0.06%
|
$54,864
$27.01 P/Share
|
|
Oct 08
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,400
-0.06%
|
$91,800
$27.01 P/Share
|
|
Oct 07
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,149
-0.04%
|
$31,023
$27.0 P/Share
|
|
Oct 07
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,149
-0.04%
|
$31,023
$27.0 P/Share
|
|
Oct 07
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
1,922
-0.04%
|
$51,894
$27.0 P/Share
|
|
Oct 04
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,711
-0.63%
|
$559,197
$27.06 P/Share
|
|
Oct 04
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
20,711
-0.63%
|
$559,197
$27.06 P/Share
|
|
Oct 04
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
34,659
-0.64%
|
$935,793
$27.06 P/Share
|
|
Oct 01
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,855
-0.21%
|
$185,085
$27.0 P/Share
|
|
Oct 01
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
6,855
-0.21%
|
$185,085
$27.0 P/Share
|
|
Oct 01
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,471
-0.21%
|
$309,717
$27.0 P/Share
|
|
Sep 30
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,292
-0.07%
|
$61,884
$27.0 P/Share
|
|
Sep 30
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
2,292
-0.07%
|
$61,884
$27.0 P/Share
|
|
Sep 30
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
3,836
-0.07%
|
$103,572
$27.0 P/Share
|
|
Sep 28
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,214
-0.58%
|
$518,778
$27.0 P/Share
|
|
Sep 28
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,214
-0.58%
|
$518,778
$27.0 P/Share
|
|
Sep 28
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
32,154
-0.59%
|
$868,158
$27.0 P/Share
|
|
Sep 27
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,625
-0.35%
|
$313,875
$27.09 P/Share
|
|
Sep 27
2021
|
Mpm Bioventures 2018, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
11,625
-0.35%
|
$313,875
$27.09 P/Share
|
|
Sep 27
2021
|
Ansbert Gadicke > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
19,455
-0.36%
|
$525,285
$27.09 P/Share
|
|
Sep 24
2021
|
Mpm Bio Ventures 2014, L.P. > 10% Shareholder |
SELL
Open market or private sale
|
Indirect |
4,913
-0.15%
|
$132,651
$27.81 P/Share
|